Janos Szebeni

Navedeno

	Vse	Od leta 2020
Navedbe	15992	6817
indeks h	61	44
indeks i10	142	91

1500

750

375

1125

199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202560 53 61 38 53 72 54 59 60 96 56 119 149 205 271 253 308 274 318 416 555 687 651 716 752 704 955 927 976 1281 1412 1320 1500 323

Javni dostop

Prikaži vse

64 člankov

2 članka

na voljo

ni na voljo

Na podlagi zahtev v povezavi s financiranjem

Soavtorji

yechezkel barenholzhebrew university of jerusalemPreverjeni e-poštni naslov na ekmd.huji.ac.il
Laszlo DezsiResearch Associate Professor of Physiology, Semmelweis UniversityPreverjeni e-poštni naslov na med.semmelweis-univ.hu
SM MoghimiProfessor of Pharmaceutics and Nanomedicine; School of Pharmacy and Institute of Cellular MedicinePreverjeni e-poštni naslov na ncl.ac.uk
Gert StormPreverjeni e-poštni naslov na uu.nl
Peter BedőcsDefense and Veterans Center for Integrative Pain Management, Uniformed Services UniversityPreverjeni e-poštni naslov na usuhs.edu
Josbert M Metselaarutrecht university, enceladus pharmaceuticals, university clinic aachen, university of twentePreverjeni e-poštni naslov na liposoma.org
Marina DobrovolskaiaSr.Principal Scientist, Nanotechnology Characterization Lab, NCI, LBRPreverjeni e-poštni naslov na mail.nih.gov
Gábor SzénásiInstitute of Translational Medicine, Semmelweis UniversityPreverjeni e-poštni naslov na med.semmelweis-univ.hu
John N WeinsteinMD Anderson Cancer CenterPreverjeni e-poštni naslov na mdanderson.org
Islam HamadAssociate Professor of NanomedicinePreverjeni e-poštni naslov na aum.edu.jo
Thomas L. AndresenProfessor, Technical University of DenmarkPreverjeni e-poštni naslov na nanotech.dtu.dk
Peter HamarProfessor of Medicine, Semmelweis UniversityPreverjeni e-poštni naslov na net.sote.hu
Alberto GabizonHebrew UniversityPreverjeni e-poštni naslov na ekmd.huji.ac.il
Didier LetourneurDR CNRS - INSERM U1148Preverjeni e-poštni naslov na inserm.fr
Tom Eirik MollnesUiO, NLSHPreverjeni e-poštni naslov na medisin.uio.no
Yeshayahu (Ishi) TalmonThe Wolfson Dept. of Chemical Engineering, Technion - Israel Institute of TechnologyPreverjeni e-poštni naslov na technion.ac.il
Dganit DaninoCryo-EM and Self-Assembly of Soft Matter, Technion, IsraelPreverjeni e-poštni naslov na technion.ac.il
Locatelli FrancoUniversity of Pavia, Ospedale Bambino Gesù, Roma, Policlinico San MatteoPreverjeni e-poštni naslov na opbg.net
Weiss GuenterProfessor of Medicine and Biochemistry, Medical Unvierstiy of Innsbruck, AustriaPreverjeni e-poštni naslov na i-med.ac.at
Amr Abu LilaProfessor of Pharmaceuticsand Industrial Pharmacy, Faculty of Pharmacy, Zagazig UniversityPreverjeni e-poštni naslov na zu.edu.eg

Spremljaj

Janos Szebeni

Nanomedicine Research and Education Center, Semmelweis University

Preverjeni e-poštni naslov na seroscience.com

liposomes complement system immune toxicology


Naslov Razvrsti po navedbah Razvrsti po letniku Razvrsti po naslovu	Navedeno Navedeno	Leto
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties SM Moghimi, J Szebeni Progress in lipid research 42 (6), 463-478, 2003	1654	2003
Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity J Szebeni Toxicology 216 (2-3), 106-121, 2005	728	2005
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions A Chanan-Khan, J Szebeni, S Savay, L Liebes, NM Rafique, CR Alving, ... Annals of Oncology 14 (9), 1430-1437, 2003	571	2003
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention J Szebeni, F Muggia, A Gabizon, Y Barenholz Advanced drug delivery reviews 63 (12), 1020-1030, 2011	510	2011
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals GT Kozma, T Shimizu, T Ishida, J Szebeni Advanced drug delivery reviews 154, 163-175, 2020	486	2020
PEGylated liposomes: immunological responses M Mohamed, AS Abu Lila, T Shimizu, E Alaaeldin, A Hussein, HA Sarhan, ... Science and technology of advanced materials 20 (1), 710-724, 2019	470	2019
Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals J Szebeni Molecular immunology 61 (2), 163-173, 2014	453	2014
Complement Activation by Cremophor EL as a Possible Contributor to Hypersensitivity to Paclitaxel: an In Vitro Study J Szebeni, CR Alving, FM Muggia JNCI: Journal of the National Cancer Institute 90 (4), 300-306, 1998	432	1998
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives D Shi, D Beasock, A Fessler, J Szebeni, JY Ljubimova, KA Afonin, ... Advanced drug delivery reviews 180, 114079, 2022	353	2022
Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management D Rampton, J Folkersen, S Fishbane, M Hedenus, S Howaldt, F Locatelli, ... haematologica 99 (11), 1671, 2014	334	2014
Poly (ethylene glycol) s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process I Hamad, AC Hunter, J Szebeni, SM Moghimi Molecular immunology 46 (2), 225-232, 2008	312	2008
F(ab)′₂-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins M Basta, F Van Goor, S Luccioli, EM Billings, AO Vortmeyer, L Baranyi, ... Nature medicine 9 (4), 431-438, 2003	304	2003
Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20 Z Weiszhár, J Czúcz, C Révész, L Rosivall, J Szebeni, Z Rozsnyay European journal of pharmaceutical sciences 45 (4), 492-498, 2012	286	2012
Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome J Szebeni, P Bedőcs, Z Rozsnyay, Z Weiszhár, R Urbanics, L Rosivall, ... Nanomedicine: Nanotechnology, Biology and Medicine 8 (2), 176-184, 2012	267	2012
Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies J Szebeni, L Baranyi, S Savay, J Milosevits, R Bunger, P Laverman, ... Journal of liposome research 12 (1-2), 165-172, 2002	261	2002
Methylation of the phosphate oxygen moiety of phospholipid‐methoxy (polyethylene glycol) conjugate prevents PEGylated liposome‐mediated complement activation and anaphylatoxin … S Moein Moghimi, I Hamad, TL Andresen, K Jørgensen, J Szebeni, ... The FASEB journal 20 (14), 2591-2593, 2006	246	2006
Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes: role of complement and … J Szebeni, JL Fontana, NM Wassef, PD Mongan, DS Morse, DE Dobbins, ... Circulation 99 (17), 2302-2309, 1999	241	1999
Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles J Szebeni, CR Alving, L Rosivall, R Bünger, L Baranyi, P Bedöcs, M Tóth, ... Journal of liposome research 17 (2), 107-117, 2007	239	2007
Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction J Szebeni, L Baranyi, S Savay, M Bodo, DS Morse, M Basta, GL Stahl, ... American Journal of Physiology-Heart and Circulatory Physiology 279 (3 …, 2000	225	2000
Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents J Szebeni Critical Reviews™ in Therapeutic Drug Carrier Systems 18 (6), 2001	209	2001

Sistem trenutno ne more izvesti postopka. Poskusite znova pozneje.

Članki 1–20

Št. navedb na leto

Podvojene navedbe

Združene navedbe

Dodajanje soavtorjevSoavtorji

Spremljaj

Navedeno

Soavtorji